Tailored Isavuconazole Dosing for Older Adults With Fungal Infections
Part of Infections clinical trials.
This trial aims to personalize the dose of the antifungal drug isavuconazole for adults over 60 with invasive aspergillosis or mucormycosis. By monitoring drug levels in the blood, doctors hope to improve treatment effectiveness and safety specifically for older patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 60 years old or older.
- You have a serious fungal infection called invasive aspergillosis or mucormycosis.
- You are about to start or are already taking the antifungal medication isavuconazole.
- Your treatment with isavuconazole is expected to last at least 48 hours.
- You are healthy enough to have blood drawn.
- You are willing to sign a consent form to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study monitors how the antifungal drug isavuconazole works in children's bodies. It aims to find the right dose for treating serious fungal infections.
This study tests how well and how safely the antifungal drug isavuconazole works in critically ill adults in intensive care who have a fungal infection (invasive fungal infection). If you are in the ICU with a suspected or confirmed fungal infection, you may be able to join.
This study is testing a personalized way to decide the first maintenance dose of voriconazole, an antifungal medicine for people with blood cancers. It uses a genetic test to help determine the best dose for you.
This trial tests a combination of antifungal medicines (liposomal amphotericin B and either isavuconazole or posaconazole) for people with blood cancers who develop a fungal infection despite taking preventive antifungal drugs. It aims to find a better treatment for these difficult infections.
This trial tests if using genetic information can help doctors choose the right dose of the antifungal drug voriconazole. It aims to improve treatment and reduce side effects for people with fungal infections.
This trial tests a personalized way of giving a strong antibiotic (ceftazidime-avibactam) to older adults. Doctors adjust the dose based on your own body's handling of the drug, aiming to make treatment safer and more effective.
Hear when a new Isavuconazole trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.